1Barbero S, Bonavia R, Bajetto A ,et al. Stromal cell- derived factor lalpha stimulates human glioblastoma cell growth through the activation of both extracellular signal - regulated kinases 1/2 and Akt. Cancer Res, 2003,63 (8) : 1969 - 1974.
2Kryczek I, Wei S, Keller E, et al. Stroma - derived factor (SDF - 1/CXCL12 ) and human tumor pathogenesis. Am J Physiol Cell Physiol,2007,292 (3) : C987 - 995.
3Fernandez E J, Lolis E. Structure, function, and inhibition of chemokines. Annu Rev Pharmacol Toxicol,2002,42(6) :469 - 499.
4Muller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature, 2001 ,410 (6824) :24 - 25.
5Peled A,Kollet O, Ponomaryov T, et al. The chemokine SDF - 1 activates the integrins LFA - 1, VLA - 4, and VLA - 5 on immature human CD34 ( + ) cells:role in transendothelial/stromal migration and engraftment of NOD/SCID mice. Blood,2000,95 ( 11 ) :3289 - 3296.
6Gao H, Priebe W, Glod J, et al. Activation of signal transducers and activators of transcription 3 and focal adhesion kinase by stromal cell -derived factor I is required for migration of human mesenchymal stem ceils in response to tumor cell - conditioned medium. Stem Cells, 2009,27 (4) : 857 - 865.
7Huang CY, Lee CY, Chen MY, et al. Stromal cell - derived factor - 1/CXCR4 enhanced motility of human osteosarcoma cells involves MEK1/2, ERK and NF - kappaB - dependent pathways. J Cell Physiol,2009,221 ( 1 ) :204 - 212.
8Lu DY, Tang CH, Yeh WL, et al. SDF - 1 alpha up - regulates interleukin - 6 through CXCR4, PI3K/Akt, ERK, and NF - kappaB - dependent pathway in microglia. Eur J Pharmacol,2009,613 ( 1 - 3 ) : 146 - 154.
9Shen X,Wang S,Wang H ,et al. The role of SDF - 1/CXCR4 axis in ovarian cancer metastasis. J Huazhong Univ Sci Technolg Med Sci ,2009,29 (3) : 363 - 367.
10Liang Z, Brooks J, Willard M, etal. CXCR4/CXCL12 axis promotes VEGF - mediated tumor angiogenesis through Akt signaling pathway. Biochem Biophys Res Commun, 2007, 359(3) :716 -722.
2Ryska M,DuseK L, Ryska O, et al. Quality of life is an im- portant factor in the indication in patients with advanced pan- creatic carcinoma- -a prospective mu lticentric study[ J ]. Rozhl Chir ,2012,91 (4) : 199 - 208.
3Hanahan D , Folkman J. Patterns and emerging mechanisms of the Angiogene sis swith during Tumorigensis [ J ] . Cell , 1996,86 : 1337 - 1347.
4Ikeda N, Adachi M, Taki T. et al. Prognostic significance of angiogenesis in human pancreatic cancer[J]. Br J Cancer . 1999,79(9 - 10) :1553 - 1563.
5Enholm B, Karpanen T, Jehsch M. et al. Adenoviral expres- sion of vascular endothelial growth factor C induces lym- phangiogenesisin the skin [ J]. Circ Res, 2007,88 (2) : 623 - 629.
6Huang C ,Huang R,Chang W. et al. The expression and clini- cal significanc e of pSTATS, VEGF and VEGF - C in pancre- atic adenocarcinoma[ J ]. Neoplasma ,2012,59 ( 1 ) :52 - 61.
7Smith RA, Tang J, Tudur - Smith C. Meta - analysis of im- munohistochemical prognostic markers in resected pancreatic cancer [ J ]. Sr J Cancer,2011,104 (9): 14d0 - 1451.
8Adams J M, Difazio L T, Rolandelli R H, et al. HIF - 1 : a key mediator in Hypoxia [ J]. Acta Physiol Hung ,2009,96( 1 ) : 19 -28.
9Calvani M, Comito G, Giannoni E. et al. Time - dependent stabilization of hypoxia inducible factor - 1 a by different in- tracellular sources of reactive oxygen species [ J ]. PLoS One, 2012,7(10) :e383888.
